Levonorgestrel Intrauterine Device Placement in a Premenopausal Breast Cancer Patient with a Bicornuate Uterus.

Abstract

Young women with breast cancer face contraceptive challenges. Data are limited and conflicting on the use of the levonorgestrel intrauterine device (LNG-IUD) in this patient population. A 32-year-old nulligravid woman with a history of breast cancer on tamoxifen presented with new-onset vaginal bleeding. Further workup revealed a previously undiagnosed bicornuate uterus. She underwent hysteroscopy, dilation and curettage, and LNG-IUD placement in each uterine horn. Postoperative follow-up confirmed retention and proper placement of both IUDs. Pathology from the dilation and curettage was benign, and the abnormal uterine bleeding abated. LNG-IUD placement in a young patient with a personal history of breast cancer on tamoxifen and a bicornuate uterus is a safe and feasible alternative for contraception.

• Authors: Ashley M Eskew, Erin K Crane
• Journal: Journal of minimally invasive gynecology (J Minim Invasive Gynecol) Vol. 23 Issue 1 Pg. 133-5 (Jan 2016) ISSN: 1553-4669 [Electronic] United States
• PMID: 26342448 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2016 AAGL. Published by Elsevier Inc. All rights reserved.

Chemical References

• Antineoplastic Agents, Hormonal
• Tamoxifen
• Levonorgestrel

Topics

• Adult
• Antineoplastic Agents, Hormonal (administration & dosage, adverse effects)
• Breast Neoplasms (drug therapy)
• Female
• Humans
• Intrauterine Devices, Medicated
• Levonorgestrel (therapeutic use)
• Tamoxifen (administration & dosage, adverse effects)
• Treatment Outcome
• Urogenital Abnormalities
• Uterine Hemorrhage (chemically induced, drug therapy)
• Uterus (abnormalities, drug effects)